Trophoblast cell surface antigen-2 (TROP-2) is a transmembrane glycoprotein that is overexpressed in multiple epithelial tumors and has been implicated in aggressive tumor biology and poor clinical outcomes [9–12]. Here, TACSTD2 is linked to neoplasm.